SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-21-138285
Filing Date
2021-11-15
Accepted
2021-11-12 18:42:27
Documents
84
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 FORM - 10Q huma-20211231x10q.htm   iXBRL 10-Q 1766053
2 EX-31.1 huma-20211231xex31d1.htm EX-31.1 17357
3 EX-31.2 huma-20211231xex31d2.htm EX-31.2 16399
4 EX-32.1 huma-20211231xex32d1.htm EX-32.1 6345
5 EX-32.2 huma-20211231xex32d2.htm EX-32.2 6356
  Complete submission text file 0001104659-21-138285.txt   8035927

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA huma-20211231.xsd EX-101.SCH 73518
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE huma-20211231_cal.xml EX-101.CAL 53390
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE huma-20211231_def.xml EX-101.DEF 264083
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE huma-20211231_lab.xml EX-101.LAB 569144
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE huma-20211231_pre.xml EX-101.PRE 445334
11 EXTRACTED XBRL INSTANCE DOCUMENT huma-20211231x10q_htm.xml XML 1355811
Mailing Address 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713
Business Address 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713 919-313-9633
Humacyte, Inc. (Filer) CIK: 0001818382 (see all company filings)

IRS No.: 851763759 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39532 | Film No.: 211405499
SIC: 2836 Biological Products, (No Diagnostic Substances)